UK will accept EU pharma testing even if no Brexit deal struck

European pharmaceutical companies will be able to supply their medicines in the UK on the basis of approved batch testing carried out in the EU for at least two years from the point the UK leaves the EU in the event of a ‘no deal’ Brexit, according to the UK government.